# Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

> **NCT03624244** · PHASE2 · RECRUITING · sponsor: **Centre Leon Berard** · enrollment: 40 (estimated)

## Conditions studied

- Low Grade Endometrial Stromal Sarcoma

## Interventions

- **DRUG:** Aromatase Inhibitors

## Key facts

- **NCT ID:** NCT03624244
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-23
- **Primary completion:** 2028-01
- **Final completion:** 2031-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03624244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03624244, "Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03624244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*